FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078270239> ?p ?o ?g. }

• W2078270239 endingPage "314" @default.
• W2078270239 startingPage "305" @default.
• W2078270239 abstract "We evaluated the ability of a short course of treatment with the ribonucleotide reductase (RR) inhibitor hydroxyurea (HU) and two novel RR inhibitors Trimidox (TX) and Didox (DX) to influence late-stage murine retrovirus-induced lymphoproliferative disease. LPBM5 murine leukaemia virus retrovirus-infected mice were treated daily with HU, TX or DX for 4 weeks, beginning 9 weeks post-infection, after development of immunodeficiency and lymphoproliferative disease. Drug effects on disease progression were determined by evaluating spleen weight and histology. Effects on haematopoiesis were determined by measuring peripheral blood indices (white blood cells and haematocrit) and assay of femur cellularity and femoral and splenic content of colony-forming units granulocytemacrophage (CFU-GM) and burst-forming units-erythroid (BFU-E). HU, TX and DX partially reversed late-stage retrovirus-induced disease, resulting in spleen weights significantly below pre-treatment values. Spleen histology was also improved by RR inhibitor treatment (DX>TX>HU). However, as expected, HU was significantly myelosuppressive, inducing a reduction in peripheral indices associated with depletion of femoral CFU-GM and BFU-E. In contrast, although TX and DX were moderately myelosuppressive, both drugs were significantly better tolerated than HU. In summary, short-term treatment in late-stage murine retroviral disease with HU, TX or DX induced dramatic reversal of disease pathophysiology. However, the novel RR inhibitors TX and DX had more effective activity and significantly less bone marrow toxicity than HU." @default.
• W2078270239 created "2016-06-24" @default.
• W2078270239 creator A5009053437 @default.
• W2078270239 creator A5014727286 @default.
• W2078270239 creator A5030037965 @default.
• W2078270239 creator A5039051365 @default.
• W2078270239 creator A5080390386 @default.
• W2078270239 date "2002-10-01" @default.
• W2078270239 modified "2023-10-16" @default.
• W2078270239 title "Short-Term Treatment with Novel Ribonucleotide Reductase Inhibitors Trimidox and Didox Reverses Late-Stage Murine Retrovirus-Induced Lymphoproliferative Disease with Less Bone Marrow Toxicity Than Hydroxyurea" @default.
• W2078270239 cites W1487377643 @default.
• W2078270239 cites W1498992791 @default.
• W2078270239 cites W1648486104 @default.
• W2078270239 cites W1952037122 @default.
• W2078270239 cites W1952244035 @default.
• W2078270239 cites W1968716613 @default.
• W2078270239 cites W1969736488 @default.
• W2078270239 cites W1977506425 @default.
• W2078270239 cites W1991584531 @default.
• W2078270239 cites W1994966130 @default.
• W2078270239 cites W1995630317 @default.
• W2078270239 cites W2010725017 @default.
• W2078270239 cites W2013496121 @default.
• W2078270239 cites W2041695570 @default.
• W2078270239 cites W2059289017 @default.
• W2078270239 cites W2064720997 @default.
• W2078270239 cites W2069322644 @default.
• W2078270239 cites W2078898097 @default.
• W2078270239 cites W2080453616 @default.
• W2078270239 cites W2084777423 @default.
• W2078270239 cites W2086887466 @default.
• W2078270239 cites W2095332267 @default.
• W2078270239 cites W2101775866 @default.
• W2078270239 cites W2163782297 @default.
• W2078270239 cites W2174167667 @default.
• W2078270239 cites W2312242170 @default.
• W2078270239 cites W2316911370 @default.
• W2078270239 cites W2317252918 @default.
• W2078270239 cites W2332258345 @default.
• W2078270239 cites W2405477634 @default.
• W2078270239 cites W4236040711 @default.
• W2078270239 cites W4245303609 @default.
• W2078270239 cites W49920453 @default.
• W2078270239 doi "https://doi.org/10.1177/095632020201300506" @default.
• W2078270239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12630679" @default.
• W2078270239 hasPublicationYear "2002" @default.
• W2078270239 type Work @default.
• W2078270239 sameAs 2078270239 @default.
• W2078270239 citedByCount "10" @default.
• W2078270239 countsByYear W20782702392019 @default.
• W2078270239 countsByYear W20782702392020 @default.
• W2078270239 crossrefType "journal-article" @default.
• W2078270239 hasAuthorship W2078270239A5009053437 @default.
• W2078270239 hasAuthorship W2078270239A5014727286 @default.
• W2078270239 hasAuthorship W2078270239A5030037965 @default.
• W2078270239 hasAuthorship W2078270239A5039051365 @default.
• W2078270239 hasAuthorship W2078270239A5080390386 @default.
• W2078270239 hasBestOaLocation W20782702391 @default.
• W2078270239 hasConcept C104292427 @default.
• W2078270239 hasConcept C104317684 @default.
• W2078270239 hasConcept C109159458 @default.
• W2078270239 hasConcept C126322002 @default.
• W2078270239 hasConcept C203014093 @default.
• W2078270239 hasConcept C2522874641 @default.
• W2078270239 hasConcept C2776694085 @default.
• W2078270239 hasConcept C2778431562 @default.
• W2078270239 hasConcept C2779316324 @default.
• W2078270239 hasConcept C2780007613 @default.
• W2078270239 hasConcept C2780931953 @default.
• W2078270239 hasConcept C28328180 @default.
• W2078270239 hasConcept C29730261 @default.
• W2078270239 hasConcept C4710235 @default.
• W2078270239 hasConcept C54355233 @default.
• W2078270239 hasConcept C55493867 @default.
• W2078270239 hasConcept C71924100 @default.
• W2078270239 hasConcept C86803240 @default.
• W2078270239 hasConceptScore W2078270239C104292427 @default.
• W2078270239 hasConceptScore W2078270239C104317684 @default.
• W2078270239 hasConceptScore W2078270239C109159458 @default.
• W2078270239 hasConceptScore W2078270239C126322002 @default.
• W2078270239 hasConceptScore W2078270239C203014093 @default.
• W2078270239 hasConceptScore W2078270239C2522874641 @default.
• W2078270239 hasConceptScore W2078270239C2776694085 @default.
• W2078270239 hasConceptScore W2078270239C2778431562 @default.
• W2078270239 hasConceptScore W2078270239C2779316324 @default.
• W2078270239 hasConceptScore W2078270239C2780007613 @default.
• W2078270239 hasConceptScore W2078270239C2780931953 @default.
• W2078270239 hasConceptScore W2078270239C28328180 @default.
• W2078270239 hasConceptScore W2078270239C29730261 @default.
• W2078270239 hasConceptScore W2078270239C4710235 @default.
• W2078270239 hasConceptScore W2078270239C54355233 @default.
• W2078270239 hasConceptScore W2078270239C55493867 @default.
• W2078270239 hasConceptScore W2078270239C71924100 @default.
• W2078270239 hasConceptScore W2078270239C86803240 @default.
• W2078270239 hasIssue "5" @default.
• W2078270239 hasLocation W20782702391 @default.
• W2078270239 hasLocation W20782702392 @default.
• W2078270239 hasOpenAccess W2078270239 @default.

• next